Gain of GRHL2 is associated with early recurrence of hepatocellular carcinoma.
Tanaka Y, Kanai F, Tada M, Tateishi R, Sanada M, Nannya Y, Ohta M, Asaoka Y, Seto M, Shiina S, Yoshida H, Kawabe T, Yokosuka O, Ogawa S, Omata M.
Tanaka Y, et al. Among authors: yoshida h.
J Hepatol. 2008 Nov;49(5):746-57. doi: 10.1016/j.jhep.2008.06.019. Epub 2008 Jul 9.
J Hepatol. 2008.
PMID: 18752864